---
figid: PMC6888001__ijms-20-05568-g007
figtitle: Agonist (e.g., histamine) binds histamine receptors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6888001
filename: ijms-20-05568-g007.jpg
figlink: /pmc/articles/PMC6888001/figure/ijms-20-05568-f007/
number: F7
caption: Agonist (e.g., histamine) binds histamine receptors. H1 couple the PLC signaling
  pathway with a stimulatory effect (+) that triggers intracellular calcium release
  (↑ Ca2+), H2 couple the AC signaling pathway with a stimulatory effect (+) that
  induces cAMP increase (↑ cAMP), and H3, H4 couple the AC signaling pathway with
  an inhibitory effect (-) that induces cAMP decrease (↓ cAMP). H1, but not H2, receptors
  stimulate cell growth in ovarian cancer cell lines (e.g., SKOV-3 and OVCAR-3 cells).
  Histamine concentration is higher in samples from ovarian carcinoma patients and
  antihistamines interfere with the hypersensitivity reactions to chemotherapeutic
  drugs.
papertitle: 'G Protein-Coupled Receptors (GPCRs)-Mediated Calcium Signaling in Ovarian
  Cancer: Focus on GPCRs activated by Neurotransmitters and Inflammation-Associated
  Molecules.'
reftext: Dragoș-Valentin Predescu, et al. Int J Mol Sci. 2019 Nov;20(22):5568.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9546028
figid_alias: PMC6888001__F7
figtype: Figure
redirect_from: /figures/PMC6888001__F7
ndex: 4718cd3b-deeb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6888001__ijms-20-05568-g007.html
  '@type': Dataset
  description: Agonist (e.g., histamine) binds histamine receptors. H1 couple the
    PLC signaling pathway with a stimulatory effect (+) that triggers intracellular
    calcium release (↑ Ca2+), H2 couple the AC signaling pathway with a stimulatory
    effect (+) that induces cAMP increase (↑ cAMP), and H3, H4 couple the AC signaling
    pathway with an inhibitory effect (-) that induces cAMP decrease (↓ cAMP). H1,
    but not H2, receptors stimulate cell growth in ovarian cancer cell lines (e.g.,
    SKOV-3 and OVCAR-3 cells). Histamine concentration is higher in samples from ovarian
    carcinoma patients and antihistamines interfere with the hypersensitivity reactions
    to chemotherapeutic drugs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Galphaq
  - CG17760
  - CG30054
  - gas
  - Galphas
  - gd
  - Galphai
  - norpA
  - sl
  - Plc21C
  - ac
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Is
  - hi
  - GNAQ
  - GAST
  - GALNS
  - PAGR1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PROK2
  - histamine
  - TCAMP
  - Histamine
  - H2
  - Ovarian cancer
  - ovarian carcinoma
  - hypersensitivity
---
